Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 64 | 60 | 63 | 66 | 65 |
| Accounts receivable | -21 | -42 | 69 | 243 | -366 |
| Other Working Capital | 116 | 251 | 91 | -176 | -276 |
| Other Operating Activity | -875 | 114 | -1,182 | -633 | -415 |
| Operating Cash Flow | $-715 | $382 | $-959 | $-500 | $-992 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | 0 | -3 | -3 | -2 |
| Purchase Sale Intangibles | -24 | -6 | -10 | -8 | -49 |
| Other Investing Activity | 0 | -53 | 0 | 0 | -20 |
| Investing Cash Flow | $-33 | $-59 | $-12 | $-12 | $-71 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 0 | 1,010 | 0 | 2 |
| Debt Repayment | -47 | -152 | -25 | -25 | -32 |
| Common Stock Issued | 415 | N/A | N/A | 0 | 0 |
| Other Financing Activity | -143 | -16 | -127 | 385 | -184 |
| Financing Cash Flow | $1,225 | $-168 | $857 | $360 | $-215 |
| Beginning Cash Position | 1,146 | 410 | 1,105 | 1,256 | 2,533 |
| End Cash Position | 1,623 | 327 | 990 | 1,105 | 1,256 |
| Net Cash Flow | $477 | $156 | $-115 | $-151 | $-1,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -715 | 382 | -959 | -500 | -992 |
| Capital Expenditure | -33 | -6 | -12 | -12 | -51 |
| Free Cash Flow | -748 | 377 | -972 | -511 | -1,042 |